Glucose-Na-K Baxter (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

Glucose-Na-K Baxter is used as an electrolyte and carbohydrate source in intravenous therapy to support patients who require fluid replacement or electrolyte balance.

• Replenishment of potassium, sodium, and magnesium in patients with electrolyte depletion.
• Provision of glucose for energy metabolism during peri-operative or critical-care periods.
• Maintenance of acid-base balance when combined with sodium acetate.
• Support of intravenous fluid therapy in patients unable to tolerate oral intake.
• Dilution and administration of other intravenous medications that require a compatible electrolyte carrier.

Adverse reactions to Glucose-Na-K Baxter are generally infrequent, but they may occur with any intravenous solution. These effects are typically monitored by laboratory tests and clinical observation during and after the infusion.

Common

• Mild irritation at the infusion site, such as erythema or discomfort.
• Transient increase in serum potassium or magnesium levels that resolves without intervention.
• Slight hyperglycemia in patients receiving large volumes.
• Nausea or headache during infusion.
• Local phlebitis due to solution osmolarity.

Serious

• Severe hyperkalemia leading to cardiac arrhythmia.
• Hypermagnesemia causing hypotension, respiratory depression, or cardiac conduction abnormalities.
• Acute fluid overload with pulmonary edema.

Glucose-Na-K Baxter should be administered only after careful assessment of the patient’s clinical status and laboratory values.

• Verify electrolyte concentrations (Na+, K+, Mg2+) before infusion.
• Adjust infusion rate in patients with renal impairment or heart failure.
• Avoid rapid administration in neonates or patients at risk of fluid overload.
• Monitor blood glucose levels, especially in diabetic patients.
• Use aseptic technique to prevent contamination.
• Discontinue if signs of allergic reaction or infusion site inflammation appear.

Certain medications and clinical conditions may alter the safety or effectiveness of Glucose-Na-K Baxter when given intravenously.

Avoid

• Concurrent infusion of potassium-sparing diuretics or ACE inhibitors in patients with hyperkalemia risk.
• Co-administration with other magnesium-containing solutions that could cause excess magnesium.
• Use with hypertonic glucose solutions that may increase osmolar load.

Use with caution

• Loop diuretics that promote electrolyte loss; monitor levels closely.
• Calcium channel blockers; watch for additive effects on cardiac conduction.
• Blood products; ensure compatible electrolyte balance.